# Albert Invent

> Chemistry-native AI and data operating system for enterprise materials and formulation R&D.

## Why it is interesting

Albert is applying vertical AI to a data-heavy industrial workflow where failed experiments and tacit knowledge are often trapped in notebooks and spreadsheets.

## Profile

- **Latest funding:** Series B — $55 million (October 13, 2026)
- **Latest known valuation:** Approximately $340 million, reported by Forbes (October 13, 2026)
- **Total disclosed equity funding:** $55M
- **Stage:** series-b
- **Status:** private
- **Industries:** ai-ml, biotech-life-sciences, enterprise-saas
- **Coverage:** full
- **Last updated:** 2026-10-14T06:15:00.000Z
- **Latest funding investors:** TCV, Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, Legion VC, Coatue, J.P. Morgan Growth Equity Partners, Index Ventures, Applied Ventures

## Key facts

- $55 million Series B led by TCV.
- Approximately $340 million valuation reported by Forbes, not disclosed by the company.
- Project creation grew 26x year over year and scientist users grew 6x, according to Albert.

## Funding history

- Series B · $55 million · October 13, 2026
  Source: https://www.businesswire.com/news/home/20261013059321/en/Albert-Raises-$55M-Series-B-to-Scale-the-First-Chemistry-Native-AI

## Investors in our directory

- https://venturecapitaltracker.com/fund/tcv
- https://venturecapitaltracker.com/fund/coatue
- https://venturecapitaltracker.com/fund/index-ventures

## Related articles

- https://venturecapitaltracker.com/albert-invent-55m-series-b-chemistry-ai

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 14, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/albert-invent